May 19, 2026 - 10:04

A new lawsuit accuses Disney of illegally collecting and storing biometric data from visitors at Disneyland without their proper consent. The legal action centers on the company's use of facial recognition technology, which the plaintiffs argue violates Illinois privacy laws. According to the complaint, most guests are unaware that the park scans their faces when they enter, and that opting into the system is presented as a seamless part of the admission process.
The case highlights a growing national debate over the mass adoption of biometric tools at sports stadiums, concert halls, and theme parks. Critics say these systems create a privatized surveillance state, where companies build detailed profiles on millions of people without meaningful oversight. Supporters argue the technology speeds up entry and improves security, but privacy advocates counter that the trade-off is rarely explained clearly to consumers.
Disney has not yet issued a public response to the lawsuit. Legal experts say the outcome could set a precedent for how entertainment giants handle facial recognition data in the future. For now, the case adds to a wave of similar lawsuits targeting major venues over biometric privacy. The plaintiffs are seeking damages and an injunction to stop the practice until Disney obtains explicit, informed consent from every visitor.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...